Skip to main content

Advertisement

Log in

Clinicopathological features and treatment outcomes of metastatic tumors in the stomach

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The metastasis of tumors to the stomach is rare, which underlies the clinical problems regarding their diagnosis and treatment. The present review summarizes the current knowledge regarding the clinicopathological characteristics, therapeutic strategies and outcomes for metastatic tumors in the stomach. The primary malignancies of the metastatic tumors in the stomach were most often breast cancers (27.9 %), followed by lung cancer (23.8 %), esophageal cancer (19.1 %), renal cell carcinoma (RCC; 7.6 %) and malignant melanoma (7.0 %). In cases of breast cancer and RCC as the primary malignancy, the median interval between the treatment of the primary tumor and diagnosis of the metastatic tumor in the stomach (IPM) was 50–78 and 75.6 months, respectively, highlighting the fact that the metastatic spread to the stomach may occur many years after the initial treatment of the cancer. In nine patients with metastatic gastric tumors arising from ovarian cancer, an endoscopic examination revealed submucosal tumors in six patients (66.7 %), with a median IPM of 30 months. Appropriate systemic treatment for these tumors is the preferred therapeutic strategy. Although solitary metachronous gastric metastasis several years after treatment of the primary tumor is an exceptionally rare event, surgical resection of metastatic gastric tumors may be recommended to control hemorrhaging or for selected tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kobayashi O, Murakami H, Yoshida T, Cho H, Yoshikawa T, Tsuburaya A, et al. Clinical diagnosis of metastatic gastric tumors: clinicopathologic findings and prognosis of nine patients in a single cancer center. World J Surg. 2004;28:548–51.

    Article  PubMed  Google Scholar 

  2. De Palma GD, Masone S, Rega M, Simeoli I, Donisi M, Addeo P, et al. Metastatic tumors to the stomach: clinical and endoscopic features. World J Gastroenterol. 2006;12:7326–8.

    PubMed  Google Scholar 

  3. Oda I, Kondo H, Yamao T, Saito D, Ono H, Gotoda T, et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy. 2001;33:507–10.

    Article  CAS  PubMed  Google Scholar 

  4. Namikawa T, Munekage M, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Metastatic gastric tumors arising from renal cell carcinoma: clinical characteristics and outcome of this uncommon disease. Oncol Lett. 2012;4:631–6.

    PubMed Central  PubMed  Google Scholar 

  5. Taal BG, Peterse H, Boot H. Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma. Cancer. 2000;89:2214–21.

    Article  CAS  PubMed  Google Scholar 

  6. Namikawa T, Iwabu J, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K, et al. Solitary gastric metastasis from a renal cell carcinoma, presenting 23 years after radical nephrectomy. Endoscopy. 2012;44:E177–8.

    Article  PubMed  Google Scholar 

  7. Namikawa T, Kobayashi M, Hanazaki K. Metastatic gastric tumor arising from ovarian cancer. Gastrointest Endosc (in press).

  8. Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W. Gastrointestinal metastases from malignant tumors of the lung. Cancer. 1982;49:170–2.

    Article  CAS  PubMed  Google Scholar 

  9. Saito T, Iizuka T, Kato H, Watanabe H. Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer. 1985;56:2235–41.

    Article  CAS  PubMed  Google Scholar 

  10. Green LK. Hematogenous metastases to the stomach. A review of 67 cases. Cancer. 1990;65:1596–600.

    Article  CAS  PubMed  Google Scholar 

  11. Campoli PM, Ejima FH, Cardoso DM, Silva OQ, Santana Filho JB, Queiroz Barreto PA, et al. Metastatic cancer to the stomach. Gastric Cancer. 2006;9:19–25.

    Article  PubMed  Google Scholar 

  12. Ayantunde AA, Agrawal A, Parsons SL, Welch NT. Esophagogastric cancers secondary to a breast primary tumor do not require resection. World J Surg. 2007;31:1597–601.

    Article  CAS  PubMed  Google Scholar 

  13. Szynglarewicz B, Ekiert M, Forgacz J, Halon A, Skalik R, Matkowski R. The role of surgery in the treatment of colorectal metastases from primary skin melanoma. Colorectal Dis. 2012;14:e305–11.

    Article  CAS  PubMed  Google Scholar 

  14. Jung HJ, Lee HY, Kim BW, Jung SM, Kim HG, Ji JS, et al. Gastric metastasis from ovarian adenocarcinoma presenting as a submucosal tumor without ulceration. Gut Liver. 2009;3:211–4.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Akce M, Bihlmeyer S, Catanzaro A. Multiple gastric metastases from ovarian carcinoma diagnosed by endoscopic ultrasound with fine needle aspiration. Case Rep Gastrointest Med. 2012;2012:610527.

    PubMed Central  PubMed  Google Scholar 

  16. Kang WD, Kim CH, Cho MK, Kim JW, Lee JS, Ryu SY, et al. Primary epithelial ovarian carcinoma with gastric metastasis mimic gastrointestinal stromal tumor. Cancer Res Treat. 2008;40:93–6.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Schwarz RE, Klimstra DS, Turnbull AD. Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol. 1998;93:111–4.

    Article  CAS  PubMed  Google Scholar 

  18. Saunders NJ. Haematemesis due to gastric involvement by metastatic ovarian carcinoma 30 years after removal of the primary tumour. Br J Clin Pract. 1986;40:298–9.

    CAS  PubMed  Google Scholar 

  19. Taylor RR, Phillips WS, O’Connor DM, Harrison CR. Unusual intramural gastric metastasis of recurrent epithelial ovarian carcinoma. Gynecol Oncol. 1994;55:152–5.

    Article  CAS  PubMed  Google Scholar 

  20. Sangha S, Gergeos F, Freter R, Paiva LL, Jacobson BC. Diagnosis of ovarian cancer metastatic to the stomach by EUS-guided FNA. Gastrointest Endosc. 2003;58:933–5.

    Article  PubMed  Google Scholar 

  21. Pernice M, Manci N, Marchetti C, Morano G, Boni T, Bellati F, et al. Solitary gastric recurrence from ovarian carcinoma: a case report and literature review. Surg Oncol. 2006;15:267–70.

    Article  PubMed  Google Scholar 

  22. Carrara S, Doglioni C, Arcidiacono PG, Testoni PA. Gastric metastasis from ovarian carcinoma diagnosed by EUS-FNA biopsy and elastography. Gastrointest Endosc. 2011;74:223–5.

    Article  PubMed  Google Scholar 

  23. Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35:449–55.

    Article  CAS  PubMed  Google Scholar 

  24. Ahmed K, Sussman JJ, Wang J, Schmulewitz N. A case of EUS-guided FNA-related pancreatic cancer metastasis to the stomach. Gastrointest Endosc. 2011;74:231–3.

    Article  PubMed  Google Scholar 

  25. Hassan H, Vilmann P, Sharma V. Impact of EUS-guided FNA on management of gastric carcinoma. Gastrointest Endosc. 2010;71:500–4.

    Article  PubMed  Google Scholar 

  26. Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am. 2010;90:251–63.

    Article  PubMed  Google Scholar 

  27. Yamao K. Complications of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) for pancreatic lesions. J Gastroenterol. 2005;40:921–3.

    Article  PubMed  Google Scholar 

  28. Shah JN, Fraker D, Guerry D, Feldman M, Kochman ML. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc. 2004;59:923–4.

    Article  PubMed  Google Scholar 

  29. Paquin SC, Gariépy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005;61:610–1.

    Article  PubMed  Google Scholar 

  30. Chong A, Venugopal K, Segarajasingam D, Lisewski D. Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc. 2011;74:933–5.

    Article  PubMed  Google Scholar 

  31. Katanuma A, Maguchi H, Hashigo S, Kaneko M, Kin T, Yane K, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy. 2012;44:E160–1.

    Article  PubMed  Google Scholar 

  32. Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:155–62.

    Article  PubMed  Google Scholar 

  33. Putti TC, Pinder SE, Elston CW, Lee AH, Ellis IO. Breast pathology practice: most common problems in a consultation service. Histopathology. 2005;47:445–57.

    Article  CAS  PubMed  Google Scholar 

  34. Chia SY, Thike AA, Cheok PY, Tan PH. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast. 2010;19:355–9.

    Article  PubMed  Google Scholar 

  35. McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’. Am J Surg Pathol. 2001;25:1485–92.

    Article  CAS  PubMed  Google Scholar 

  36. Jones GE, Strauss DC, Forshaw MJ, Deere H, Mahedeva U, Mason RC. Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature. World J Surg Oncol. 2007;5:75.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Suzaki N, Hiraki A, Ueoka H, Aoe M, Takigawa N, Kishino T, et al. Gastric perforation due to metastasis from adenocarcinoma of the lung. Anticancer Res. 2002;22:1209–12.

    PubMed  Google Scholar 

  38. Sileri P, D’Ugo S, Blanco Gdel V, Lolli E, Franceschilli L, Formica V, et al. Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: report of a case. Int J Surg Case Rep. 2012;3:385–8.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Abdulkader I, Sánchez L, Cameselle-Teijeiro J, Gude F, Chávez JE, López-López R, et al. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. Oncol Rep. 2005;14:1527–31.

    CAS  PubMed  Google Scholar 

  40. Chung C, Christianson M. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation. J Oncol Pharm Pract; 2013 Mar 14. (Epub ahead of print).

Download references

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsutomu Namikawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Namikawa, T., Hanazaki, K. Clinicopathological features and treatment outcomes of metastatic tumors in the stomach. Surg Today 44, 1392–1399 (2014). https://doi.org/10.1007/s00595-013-0671-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-013-0671-9

Keywords

Navigation